Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Abstract Background Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been published on this topic. Conversely, proteomics approaches are not much developed, despite their adv...

Full description

Bibliographic Details
Main Authors: Jérôme Lacombe, Muriel Brengues, Alain Mangé, Céline Bourgier, Sophie Gourgou, André Pèlegrin, Mahmut Ozsahin, Jérôme Solassol, David Azria
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Radiation Oncology
Subjects:
Radiotherapy
Normal tissue radiotoxicity
AK2
Radiation-induced breast fibrosis
Radiosensitivity
Proteomics
Online Access:http://link.springer.com/article/10.1186/s13014-019-1351-8

Internet

http://link.springer.com/article/10.1186/s13014-019-1351-8

Similar Items